Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Eli Lilly and Company
Baylor College of Medicine
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Milton S. Hershey Medical Center
M.D. Anderson Cancer Center
Massachusetts General Hospital
Medical College of Wisconsin
Ann & Robert H Lurie Children's Hospital of Chicago
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cardinal Health 414, LLC
Hutchmed
University of Virginia
Memorial Sloan Kettering Cancer Center
Stanford University
Bayer
Sarcoma Alliance for Research through Collaboration
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eisai Inc.
Bristol-Myers Squibb
Children's Oncology Group
Eisai Inc.
Eisai Inc.
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
Children's Oncology Group
OHSU Knight Cancer Institute
Dana-Farber Cancer Institute
Boehringer Ingelheim
Novartis
Children's Oncology Group
Celgene
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
Sarcoma Alliance for Research through Collaboration
National Cancer Institute (NCI)